LEUKOPLAKIA ORAL

This adverse event was reported 513 times

These drugs are most commonly taken by patients reporting LEUKOPLAKIA ORAL:

# Drug Count
0 METHOTREXATE SODIUM 37
1 METHOTREXATE 29
2 ASPIRIN 22
3 ASPIRIN 325 MG 22
4 ASPIRIN 81 MG 22
5 METFORMIN 22
6 ADALIMUMAB 21
7 ALENDRONATE SODIUM 20
8 METFORMIN ER 500 MG 20
9 METFORMIN ER 750 MG 20
See all common drugs associated with LEUKOPLAKIA ORAL

LEUKOPLAKIA ORAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL 1 0.0042
1 DARIDOREXANT 8 0.0029
2 BORIC ACID 1 0.0028
3 POTASSIUM NITRATE AND SODIUM FLUORIDE 1 0.0017
4 IDARUBICIN HYDROCHLORIDE 2 0.0017
5 PROPAFENONE 7 0.0016
6 TERBUTALINE SULFATE 3 0.0016
7 TRIMETHOBENZAMIDE HYDROCHLORIDE 2 0.0014
8 BISACODYL 5MG 1 0.0011
9 OXAPROZIN 1 0.0011
See all drugs enriched for association with LEUKOPLAKIA ORAL

LEUKOPLAKIA ORAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 2 0.0029
1 Stimulant Laxative [EPC] 10 0.0007
2 Pyrethroid [EPC] 1 0.0006
3 Quinolone Antimicrobial [EPC] 5 0.0005
4 Interleukin-17 Receptor A Antagonist [EPC] 1 0.0005
5 Orexin Receptor Antagonist [EPC] 8 0.0004
6 Provitamin D2 Compound [EPC] 10 0.0003
7 Interleukin-17A Antagonist [EPC] 12 0.0003
8 Calcitonin [EPC] 1 0.0003
9 Blood Viscosity Reducer [EPC] 1 0.0002
See all drug classes enriched for association with LEUKOPLAKIA ORAL